Pharmaceutical Financial Analyst - Cambridge, United States - Aspartes Pharmaceuticals

Description

We are seeking an exceptionally talented Pharmaceutical Financial Analyst to join our team and play a crucial role in the development of a key product for an ultra-rare neurological disease.

You will be responsible for performing various types of valuations, comparative analyses, and cost estimates related to our product development efforts.

• Conduct thorough financial analysis and valuation of pharmaceutical companies and their assets, including drugs, patient populations, and patents.
• Perform due diligence investigations into potential M&A opportunities to support strategic decisionmaking.
• Develop detailed financial models and forecasts to guide investment decisions and strategic initiatives.
• Estimate accurate costs and development timelines for R&D activities and regulatory processes.
• Prepare comprehensive reports summarizing key findings and scenarios to support internal discussions and external communications.

• High level of experience in financial modeling of pharmaceutical assets, with a focus on rare diseases.
• Ability to use investigational skills to determine accurate estimates of NPV and rNPV for pharmaceutical assets.
• Proficiency in creating accurate financial models for products in development and inmarket forecasting.
• Strong knowledge in defining addressable patient populations and market shares.
• Understanding of basic pharmacology and relevant pharmaceutical sciences.
• Familiarity with the pharmaceutical supply chain and pricing dynamics.
• Proficiency in utilizing mathematical and statistical techniques to ensure model accuracy and reliability.
• Experience with modeling programs such as Excel, C++, and PowerPoint.
• Ability to analyze the commercial potential of assets currently in development.
• Skill in predicting development costs, timelines, and probabilities of success.

• Experience or familiarity working in the rare disease/orphan drug space and orphan drug economics.
• Knowledge of pricing dynamics for specialty pharmaceutical products, especially ultrarare disease assets.
• Familiarity with the regulatory approval process for smallmolecule pharmaceuticals.
• Strong understanding of US healthcare systems, including Managed Care Organizations, Medicaid/Medicare/Commercial insurance programs, pharmaceutical distribution/supply chains, and pricing negotiations.
• Basic understanding of the Canadian drug market.

• 8 hour shift

• Cambridge, MA 02139: Relocate before starting work (required)